CU6 clarity pharmaceuticals ltd

Ann: SECuRE trial update, page-154

  1. 5,504 Posts.
    lightbulb Created with Sketch. 3270
    “ Lantheus the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes”

    Lantheus could be very very interested, & keen - to secure Clarity.

    Very long established radiopharmaceutical company, long history in development and to where the company is positioned today. (since about 1956. )

    Similar market cap to Telix , & Telix is now beating them in the radiopharmaceuticals diagnostic space - Nasdaq Lantheus could likely want to best compete and position for into the future.

    https://www.prnewswire.com/news-releases/lantheus-to-acquire-evergreen-theragnostics-for-upfront-payment-of-250-million-to-drive-strategic-evolution-into-fully-integrated-radiopharmaceutical-leader-302361401.html

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.01
Change
-0.070(3.37%)
Mkt cap ! $645.9M
Open High Low Value Volume
$2.06 $2.06 $1.97 $4.379M 2.177M

Buyers (Bids)

No. Vol. Price($)
1 1500 $2.00
 

Sellers (Offers)

Price($) Vol. No.
$2.03 1387 1
View Market Depth
Last trade - 16.11pm 23/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.